GlaxoSmithKline, Novartis exchange oncology, vaccine businesses

  • April 24, 2014

GlaxoSmithKline and Novartis proposed a three-part transaction involving consumer healthcare, vaccines and oncology businesses, according to a press release. The two companies plan to create a new consumer healthcare business as part of the transaction. Emma Walmsley, president of GlaxoSmithKline consumer healthcare, will be chief executive officer of the new business and will sit on the board. Sir Andrew Witty, chief executive officer of GlaxoSmithKline, will be chairman of the board.Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Financial Planning
  • Advice for physicians
  • Be aware of important 2014 IRA updates. Analysis by Certified Financial Planner Ken Rudzinski.
More »